title: Pediatric psychopharmacology in primary care: a conceptual framework.
abstract: In a 2009 policy statement focused on children's mental health, the American Academy of Pediatrics recommended that pediatric primary care physicians achieve competence in initiating care for children with attention-deficit/hyperactivity disorder (ADHD), anxiety, depression, and substance use/abuse. Because treatment for 3 of these conditions--ADHD, anxiety, and depression--may, under certain conditions, include medication, the primary purpose of this article is to offer guidance to assist primary care physicians in decision-making about their use of psychotropic medications for these conditions. A few medications with proven efficacy and safety are emphasized. Secondarily, other medications that may be useful for other disorders are noted.
authors.affiliation: Johns Hopkins University School of Medicine, USA. mriddle1@jhmi.edu
authors.forename: Mark A
authors.initials: MA
authors.lastname: Riddle
authors.forename: Susan
authors.initials: S
authors.lastname: dosReis
authors.forename: Gloria M
authors.initials: GM
authors.lastname: Reeves
authors.forename: Lawrence S
authors.initials: LS
authors.lastname: Wissow
authors.forename: David B
authors.initials: DB
authors.lastname: Pruitt
authors.forename: Jane Meschan
authors.initials: JM
authors.lastname: Foy
mesh_terms: D000293:Adolescent; D001007:Anxiety / Q000175:diagnosis / Q000188:drug therapy; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy; D002491:Central Nervous System Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002648:Child; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007258:Informed Consent; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy*; D011320:Primary Health Care; D011600:Psychopharmacology; D012307:Risk Factors; D013405:Suicide
chemical_list: D002491:Central Nervous System Agents